These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 8454448)
1. Macrophage migration inhibition test in patients with drug-induced pemphigus. Brenner S; Halevy S; Livni E; Schewach-Millet M; Sandbank M; Wolf R Isr J Med Sci; 1993 Jan; 29(1):44-6. PubMed ID: 8454448 [No Abstract] [Full Text] [Related]
2. Macrophage migration inhibition factor in pemphigus vulgaris. Brenner S; Livni E J Am Acad Dermatol; 1986 Mar; 14(3):453-5. PubMed ID: 3514697 [TBL] [Abstract][Full Text] [Related]
3. In vitro interferon-gamma release test in patients with drug-induced pemphigus. Goldberg I; Shirazi I; Brenner S Isr Med Assoc J; 2008 Jun; 10(6):424-7. PubMed ID: 18669138 [TBL] [Abstract][Full Text] [Related]
4. [A study of clinical significance of leukocyte migration inhibition test in drug-induced hypersensitivity pneumonitis]. Uno K; Kondo A Arerugi; 1995 Dec; 44(12):1401-9. PubMed ID: 8871295 [TBL] [Abstract][Full Text] [Related]
5. [Ocular pseudo-pemphigus induced by ophthalmic solutions: apropos of 3 cases]. Saraux H; Offret H; de Rancourt de Mimerand E Bull Soc Ophtalmol Fr; 1980 Jan; 80(1):41-5. PubMed ID: 7226371 [No Abstract] [Full Text] [Related]
6. Penicillin- and ampicillin-induced pemphigus vulgaris. Fellner MJ; Mark AS Int J Dermatol; 1980 Sep; 19(7):392-3. PubMed ID: 7419319 [No Abstract] [Full Text] [Related]
7. Cefadroxil-induced ampicillin-exacerbated pemphigus vulgaris: case report and review of the literature. Wilson JP; Koren JF; Daniel RC; Chapman SW Drug Intell Clin Pharm; 1986 Mar; 20(3):219-23. PubMed ID: 3956380 [TBL] [Abstract][Full Text] [Related]
9. A case of drug-induced hypersensitivity syndrome showing transient immunosuppression before viral reactivation during treatment for pemphigus foliaceus. Takahashi H; Tanaka M; Tanikawa A; Toyohara A; Ogo Y; Morimoto A; Harato R; Kobayashi M; Amagai M Clin Exp Dermatol; 2006 Jan; 31(1):33-5. PubMed ID: 16309475 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus. Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786 [TBL] [Abstract][Full Text] [Related]
11. Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of D-penicillamine in drug-induced pemphigus foliaceus. Nagao K; Tanikawa A; Yamamoto N; Amagai M Clin Exp Dermatol; 2005 Jan; 30(1):43-5. PubMed ID: 15663502 [TBL] [Abstract][Full Text] [Related]
12. Immunostaining with antibodies to desmoglein provides the diagnosis of drug-induced pemphigus and allows prediction of outcome. Maruani A; Machet MC; Carlotti A; Giraudeau B; Vaillant L; Machet L Am J Clin Pathol; 2008 Sep; 130(3):369-74. PubMed ID: 18701409 [TBL] [Abstract][Full Text] [Related]
13. Pemphigus foliaceus induced by bucillamine. Fujita H; Iguchi M; Watanabe R; Asahina A Eur J Dermatol; 2007; 17(1):98-9. PubMed ID: 17324844 [No Abstract] [Full Text] [Related]
14. Detection of pemphigus autoantibodies by IIF and ELISA tests in patients with pemphigus vulgaris and foliaceus and in healthy relatives. Torzecka JD; Narbutt J; Sysa-Jedrzejowska A; Waszczykowska E; Lukamowicz J; Pas HH Med Sci Monit; 2003 Dec; 9(12):CR528-33. PubMed ID: 14646976 [TBL] [Abstract][Full Text] [Related]
15. A clinical study of patients with pemphigus vulgaris and pemphigus foliaceous: an 11-year retrospective study (1996-2006). Ishii N; Maeyama Y; Karashima T; Nakama T; Kusuhara M; Yasumoto S; Hashimoto T Clin Exp Dermatol; 2008 Aug; 33(5):641-3. PubMed ID: 18627388 [TBL] [Abstract][Full Text] [Related]